Authorization

35 Stocks Moving In Monday's Mid-Day Session

Gainers






Ra Medical Systems, Inc. (NYSE:RMED) shares jumped 64.8% to $8.04 on abnormally-high session volume.




EXFO Inc. (NASDAQ:EXFO) surged 60.3% to $5.93 after the company announced a going-private transaction by its found and majority shareholder, Germain Lamonde.




Liminal BioSciences Inc. (NASDAQ:LMNL) shares climbed 39.3% to $5.62. Liminal BioSciences reported the FDA approval for its Biologics License Application for Ryplazim.




U.S. Concrete, Inc. (NASDAQ:USCR) gained 29.5% to $74.00. Vulcan announced plans to acquire U.S. Concrete for $74 per share in cash.




Urban One, Inc. (NASDAQ:UONE) rose 24.1% to $16.21.




NextDecade Corporation (NASDAQ:NEXT) gained 24.1% to $3.03 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced a $6 price target.




Atossa Therapeutics, Inc. (NASDAQ:ATOS) surged 24% to $5.76. Atossa Therapeutics is scheduled to release final data from Phase 2 study of Endoxifen administered to breast cancer patients prior to surgery at webinar on June 9.




Euroseas Ltd. (NASDAQ:ESEA) jumped 21.5% to $19.70 following circulation of word fund manager Louis Navellier calls the stock a buy.




QTS Realty Trust, Inc. (NYSE:QTS) surged 21% to $78.00 on a report Blackstone agreed to buy the company for $6.7 billion, or $78 per share.




SemiLEDs Corporation (NASDAQ:LEDS) gained 19.7% to $24.55 on above-average volume.




Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 19.2% to $1.0314. Evofem Biosciences, last month, priced its 50 million shares common stock offering at $1 per share.




Bionano Genomics, Inc. (NASDAQ:BNGO) rose 17.7% to $8.09 after gaining 9% on Friday.




Clover Health Investments, Corp. (NASDAQ:CLOV) gained 16.4% to $10.48.




Asensus Surgical, Inc. (NASDAQ:ASXC) jumped 16.3% to $3.4781.




American Resources Corporation (NASDAQ:AREC) gained 16% to $3.83 after the company announced it successfully achieved a high purity of the rare earth element Neodymium using its chromatography process.




KBS Fashion Group Limited (NASDAQ:KBSF) jumped 14.8% to $3.87.




Naked Brand Group Limited (NASDAQ:NAKD) rose 14.4% to $0.7986 after dropping 15% on Friday.




First High-School Education Group Co., Ltd. (NYSE:FHS) gained 14.3% to $7.60.




Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) rose 14.1% to $3.88 after surging 24% on Friday.




View, Inc. (NASDAQ:VIEW) jumped 13.6% to $9.19.




Owens & Minor, Inc. (NYSE:OMI) surged 12.1% to $47.08.




G-III Apparel Group, Ltd. (NASDAQ:GIII) gained 11.7% to $35.11 after the company reported upbeat Q1 results and issued strong FY22 guidance.




Sundial Growers Inc. (NASDAQ:SNDL) rose 8.3% to $1.18 after dropping over 15% on Friday.




Clean Energy Fuels Corp. (NASDAQ:CLNE) rose 7.7% to $10.03.






Check out these big penny stock gainers and losers

Losers






MoSys, Inc. (NASDAQ:MOSY) shares tumbled 20.1% to $7.28 after the company announced a $13 million registered direct offering priced at $7.15.




Fuel Tech, Inc. (NASDAQ:FTEK) fell 14% to $2.52 after surging over 36% on Friday. The company, last month, reported quarterly results.




Newtek Business Services Corp. (NASDAQ:NEWT) dropped 12.3% to $33.94. Compass Point downgraded Newtek Business Services from Buy to Neutral and raised the price target from $33 to $38.




TAL Education Group (NYSE:TAL) fell 11% to $26.72 after dropping 10% on Friday.




Canaan Inc. (NASDAQ:CAN) dipped 10.4% to $9.83.




American Superconductor Corporation (NASDAQ:AMSC) dipped 10.2% to $15.75.




Frank's International N.V. (NYSE:FI) fell 9.6% to $3.37. The company, last month, reported weak quarterly results.




Cabaletta Bio, Inc. (NASDAQ:CABA) dropped 9.6% to $8.98.




ShiftPixy, Inc. (NASDAQ:PIXY) fell 7.8% to $3.1804 after jumping 21% on Friday.




Windtree Therapeutics, Inc. (NASDAQ:WINT) shares fell 7.8% to $2.4899. Windtree Therapeutics shares jumped 36% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and an $8 price target.




Purple Biotech Ltd. (NASDAQ:PPBT) fell 7.1% to $5.51. Purple Biotech recently announced new data from the first dose level cohort of its ongoing Phase 1/2 trial evaluating NT219 in various solid tumors.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Октябрь 2021    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
25262728293031